Brief: Helix Biopharma To Explore Partnership, Joint Development Or Licensing Of Drug
22/02/2018 22:29
Feb 22 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA - BOARD AUTHORIZED PROCESS TO EXPLORE
PARTNERSHIP, JOINT DEVELOPMENT OR LICENSING TRANSACTION OF CO'S
L-DOS47 DRUG PRODUCT CANDIDATE
Source text for Eikon: ID:nGNX9D9hd5
Further company coverage: HBP.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020